Circ_0006404 Accelerates Prostate Cancer Progression Through Regulating miR-1299/CFL2 Signaling

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Viktorov AA, Zharinov GM, Neklasova NJ, et al. Prediction of life expectancy for prostate cancer patients based on the kinetic theory of aging of living systems. Adv Gerontol. 2017;30(3):356–362.
   PubMedGoogle Scholar
• Kalra S, Basourakos S, Abouassi A, et al. The implications of ageing and life expectancy in prostate cancer treatment. Nat Rev Urol. 2016;13(5):289–295. doi:10.1038/nrurol.2016.52
   PubMed Web of Science ®Google Scholar
• Wang Q, Li W, Zhang Y, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 2009;138(2):245–256. doi:10.1016/j.cell.2009.04.056
   PubMed Web of Science ®Google Scholar
• Misawa A, Takayama K, Urano T, et al. Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells. J Biol Chem. 2016;291(34):17861–17880. doi:10.1074/jbc.M116.718536
   PubMed Web of Science ®Google Scholar
• Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med Life. 2017;10(1):5–12.
   PubMedGoogle Scholar
• Fong MK, Hare R, Jarkowski A. A new era for castrate resistant prostate cancer: a treatment review and update. J Oncol Pharm Pract. 2012;18(3):343–354. doi:10.1177/1078155212437599
   PubMedGoogle Scholar
• Rodrigues DN, Butler LM, Estelles DL, et al. Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol. 2014;232(2):178–184. doi:10.1002/path.4272
   PubMed Web of Science ®Google Scholar
• Petkovic S, Müller S. RNA circularization strategies in vivo and in vitro. Nucleic Acids Res. 2015;43(4):2454–2465. doi:10.1093/nar/gkv045
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51. doi:10.1016/j.jbiotec.2016.09.011
   PubMed Web of Science ®Google Scholar
• Kong Z, Wan X, Lu Y, et al. Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. J Cell Mol Med. 2020;24(1):799–813. doi:10.1111/jcmm.14791
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhou L, Zhang C, et al. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2020;468:88–101. doi:10.1016/j.canlet.2019.10.006
   PubMed Web of Science ®Google Scholar
• Wu CL, Ho JY, Chou SC, et al. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer. Oncotarget. 2016;7(18):26593–26603. doi:10.18632/oncotarget.8557
   PubMedGoogle Scholar
• Zhang X, Xu Y, Yamaguchi K, et al. Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis. Cancer Cell Int. 2020;20:103. doi:10.1186/s12935-020-01178-y
   PubMed Web of Science ®Google Scholar
• Zhou G, Shen M, Zhang Z. ZW10 binding factor (ZWINT), a direct target of Mir-204, predicts poor survival and promotes proliferation in breast cancer. Med Sci Monit. 2020;26:e921659. doi:10.12659/MSM.921659
   PubMed Web of Science ®Google Scholar
• Antognelli C, Cecchetti R, Riuzzi F, et al. Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control. J Cell Mol Med. 2018;22(5):2865–2883. doi:10.1111/jcmm.13581
   PubMed Web of Science ®Google Scholar
• Lin L, Cai J. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation. J Cell Biochem. 2020;121(11):4377–4385. doi:10.1002/jcb.29620
   PubMed Web of Science ®Google Scholar
• Zhang FB, Du Y, Tian Y, et al. MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2. Eur Rev Med Pharmacol Sci. 2019;23(2):530–538. doi:10.26355/eurrev_201901_16865
   PubMed Web of Science ®Google Scholar
• Luo D, Wilson JM, Harvel N, et al. A systematic evaluation of miRNA: mRNAinteractions involved in the migration and invasion of breast cancer cells. J Transl Med. 2013;11:57. doi:10.1186/1479-5876-11-57
   PubMed Web of Science ®Google Scholar
• Bian Y, Guo J, Qiao L, et al. miR-3189-3p mimics enhance the effects of S100A4 siRNA on the inhibition of proliferation and migration of gastric cancer cells by targeting CFL2. Int J Mol Sci. 2018;19(1):236. doi:10.3390/ijms19010236
   PubMed Web of Science ®Google Scholar
• Wo Q, Zhang D, Hu L, et al. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis. Biochem Biophys Res Commun. 2019;520(3):586–593. doi:10.1016/j.bbrc.2019.09.108
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang G, Zhou X, et al. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6. Biomed Pharmacother. 2016;83:792–797. doi:10.1016/j.biopha.2016.07.037
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045. doi:10.1080/15476286.2016.1271524
   PubMed Web of Science ®Google Scholar
• Eger N, Schoppe L, Schuster S, et al. Circular RNA splicing. Adv Exp Med Biol. 2018;1087:(41–52.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–2092. doi:10.2147/OTT.S233672
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319–336. doi:10.1016/j.trecan.2020.01.012
   PubMed Web of Science ®Google Scholar
• Ji W, Qiu C, Wang M, et al. Hsa_circ_0001649: a circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018;497(1):122–126. doi:10.1016/j.bbrc.2018.02.036
   PubMed Web of Science ®Google Scholar
• Yin WB, Yan MG, Fang X, et al. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta. 2018;487:363–368. doi:10.1016/j.cca.2017.10.011
   PubMed Web of Science ®Google Scholar
• Zhang S, Liao K, Miao Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Neuro Oncol. 2019;21(10):1284–1296. doi:10.1093/neuonc/noz128
   PubMed Web of Science ®Google Scholar
• Gao AM, Yuan C, Hu AX, et al. circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression. Cell Signal. 2020;72:109622. doi:10.1016/j.cellsig.2020.109622
   PubMed Web of Science ®Google Scholar
• Zhang L, Bu Z, Shen J, et al. A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A. Biomed Pharmacother. 2020;122:(109619. doi:10.1016/j.biopha.2019.109619
   Web of Science ®Google Scholar